CPRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Catalyst Pharmaceuticals Inc (CPRX) does not present a strong buy opportunity for a beginner investor with a long-term strategy at this time. While the technical indicators show some bullish trends, the lack of significant positive catalysts, neutral trading sentiment, and declining financial performance make it prudent to hold off on investing in this stock currently.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram (0.166), suggesting a slight upward momentum. RSI is neutral at 65.579, and the stock is trading near its resistance level (R1: 26.19). However, the pre-market change of -1.08% indicates some short-term weakness.
Analyst Samantha Semenkow raised the price target to $35 from $33 with a Buy rating. The stock's bullish moving averages and positive MACD contraction support a potential upward trend.
Hedge funds and insiders are neutral, and there is no recent congress trading data.
In Q4 2025, revenue increased by 7.61% YoY to $152.61M. However, net income dropped by 5.79% YoY to $52.7M, EPS declined by 6.82% to 0.41, and gross margin decreased by 1.84% to 76.71%.
Citi analyst Samantha Semenkow raised the price target from $33 to $35 and maintained a Buy rating, reflecting optimism about the stock's future potential.
